- Q1 2024 FibroGen Inc Earnings Call TranscriptMay 06, 2024MXN20.25 (-6.98%)Earnings
- Q4 2023 FibroGen Inc Earnings Call TranscriptFeb 26, 2024MXN30 (-20.09%)Earnings
- FibroGen Inc KOL Investor Event Series Part I (Virtual) TranscriptFeb 13, 2024
- Q3 2023 FibroGen Inc Earnings Call TranscriptNov 06, 2023MXN15.08Earnings
- Q2 2023 FibroGen Inc Earnings Call TranscriptAug 07, 2023MXN31 (-90.91%)Earnings
- FibroGen Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- FibroGen Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 FibroGen Inc Earnings Call TranscriptMay 08, 2023MXN341.2Earnings
- Q4 2022 FibroGen Inc Earnings Call TranscriptFeb 27, 2023MXN461.5Earnings
- FibroGen Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Q3 2022 FibroGen Inc Earnings Call TranscriptNov 07, 2022MXN350.5Earnings
- Q2 2022 FibroGen Inc Earnings Call TranscriptAug 08, 2022MXN251Earnings
- Q1 2022 FibroGen Inc Earnings Call TranscriptMay 09, 2022MXN257.5Earnings
- Q4 2021 FibroGen Inc Earnings Call TranscriptFeb 28, 2022MXN314Earnings
- Q3 2021 FibroGen Inc Earnings Call TranscriptNov 09, 2021MXN246 (-8.21%)Earnings
- Q2 2021 FibroGen Inc Earnings Call TranscriptAug 09, 2021MXN278 (+0.36%)Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- FibroGen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2021
- FibroGen Inc Annual Shareholders Meeting TranscriptMay 26, 2021
- FibroGen Inc at Bank of America Global Research Healthcare Conference (Virtual) - Fireside Chat TranscriptMay 13, 2021
- Q1 2021 FibroGen Inc Earnings Call TranscriptMay 10, 2021MXN386.14 (-6.25%)Earnings
- FibroGen Inc Provides Additional Information on Roxadustat - Conference Call TranscriptApr 06, 2021
- FibroGen Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 FibroGen Inc Earnings Call TranscriptMar 01, 2021MXN1037Earnings
- FibroGen Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- FibroGen Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- Q3 2020 FibroGen Inc Earnings Call TranscriptNov 05, 2020MXN1012Earnings
- FibroGen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- FibroGen Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Q2 2020 FibroGen Inc Earnings Call TranscriptAug 06, 2020MXN987Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- FibroGen Inc Annual Shareholders Meeting TranscriptJun 04, 2020
- FibroGen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- FibroGen Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 FibroGen Inc Earnings Call TranscriptMay 07, 2020MXN900Earnings
- Q4 2019 FibroGen Inc Earnings Call TranscriptMar 02, 2020MXN800 (-2.91%)Earnings
- FibroGen Inc at Leerink Global Healthcare Conference TranscriptFeb 25, 2020
- Q3 2019 FibroGen Inc Earnings Call TranscriptNov 11, 2019MXN645Earnings
- Q2 2019 FibroGen Inc Earnings Call TranscriptAug 08, 2019MXN740Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Q1 2019 FibroGen Inc Earnings Call TranscriptMay 09, 2019MXN890Earnings
- Q4 2018 FibroGen Inc Earnings Call TranscriptFeb 27, 2019MXN865Earnings
Q3 2023 FibroGen Inc Earnings Call Transcript
Hello and welcome to FibroGen's Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. (Operator Instructions). Please be advised that today's conference is being recorded. It is now my pleasure to introduce Vice President of Investor Relations, David DeLucia.
Good afternoon, everyone. Thank you for joining today to discuss our third quarter 2023 financial and business results. I'm David DeLucia, Vice President of Corporate FP&A and Investor Relations of FibroGen. Joining me on today's call are Thane Wettig, our Chief Executive Officer; Juan Graham, our Chief Financial Officer; Dr. John Hunter, our Chief Scientific Officer; and Christine Chung, our Senior Vice President of China Operations.
Following our prepared remarks, we will open the call to your questions. I would like to remind you that remarks made on today's call include forward-looking statements about FibroGen. Such statements may include, but are not limited to, our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)